AVP and metabolic syndrome: Insulin resistance and high insulin levels increase insulin-regulated aminopeptidase (IRAP) activity, which accelerates AVP degradation and triggers a compensatory rise in AVP synthesis, potentially contributing to the development of metabolic syndrome [36].